Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bristol-myers squibb company    crawled date : 2021 - 03 - 19    save search
Written Requests Issued
Published: 2021-03-19 (Crawled : 19:47) - fda.gov
LLY | $745.95 -0.64% -0.13% 17K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BMY | $48.3 0.96% 0.21% 3.3K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.08% 190K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MRK | $125.23 -0.11% 0.41% 1K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
PTCT | $24.69 -1.87% -1.82% 820K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GILD | News | $66.16 -1.15% -1.16% 1.4K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ABT | News | $105.27 -0.6% -0.38% 5.9M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $45.39 -1.56% -1.58% 4.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-19 (Crawled : 18:32) - fda.gov
LLY | $745.95 -0.64% -0.13% 17K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
OMER | $3.21 -3.89% -3.73% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
OTIC | $0.077 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BMY | $48.3 0.96% 0.21% 3.3K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BCRX | $4.5 -1.75% -2.0% 900 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.08% 190K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BMRN S | $90.07 -0.44% -0.43% 220 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SUPN | $28.87 -0.45% -0.42% 1 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
AMGN | $262.75 -0.5% -0.49% 320 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GILD | News | $66.16 -1.15% -1.16% 1.4K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ABBV | News | $164.66 0.25% -0.55% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $45.39 -1.56% -1.58% 4.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Published: 2021-03-19 (Crawled : 12:00) - biospace.com/
BMY | $48.3 0.96% 0.21% 3.3K twitter stocktwits trandingview |
Health Technology
 | | O: -0.42% H: 1.1% C: 1.01%
food fda drug cardio fda acceptance mavacamten application
Gainers vs Losers
54% 46%

Top 10 Gainers
HUBC | $1.52 17.83% 4.7M twitter stocktwits trandingview |
n/a
NVCT | $6.88 2.38% 2.8K twitter stocktwits trandingview |

BKNG | $3456.65 0.77% 13K twitter stocktwits trandingview |
Consumer Services
ED | News | $91.43 0.58% 75K twitter stocktwits trandingview |
Utilities
MBI | $6.075 0.41% 12K twitter stocktwits trandingview |
Finance
CWST | $92.75 0.41% 13K twitter stocktwits trandingview |
Industrial Services
BCS | $9.27 0.33% 140K twitter stocktwits trandingview |
Finance
RVMD S | $35.86 0.08% 36K twitter stocktwits trandingview |
Health Technology
BIIB | $190.59 0.04% 50K twitter stocktwits trandingview |
Health Technology
CMG | $2898.49 -0.33% 290 twitter stocktwits trandingview |
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.